SynBiotic Balance Sheet Health
Financial Health criteria checks 1/6
SynBiotic has a total shareholder equity of €15.3M and total debt of €3.6M, which brings its debt-to-equity ratio to 23.7%. Its total assets and total liabilities are €34.9M and €19.6M respectively.
Key information
23.7%
Debt to equity ratio
€3.63m
Debt
| Interest coverage ratio | n/a |
| Cash | €2.07m |
| Equity | €15.33m |
| Total liabilities | €19.59m |
| Total assets | €34.92m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SBX's short term assets (€6.5M) do not cover its short term liabilities (€8.0M).
Long Term Liabilities: SBX's short term assets (€6.5M) do not cover its long term liabilities (€11.6M).
Debt to Equity History and Analysis
Debt Level: SBX's net debt to equity ratio (10.2%) is considered satisfactory.
Reducing Debt: SBX's debt to equity ratio has increased from 0% to 23.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if SBX has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if SBX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.